Vocal biomarkers
are a novel technique developed to detect the presence of disease from speech
characteristics. By decoding the vocal intonations in real-time, the technology
can provide holistic treatment and quality patient care. The global vocal
biomarkers market report by Market Research Future (MRFR) highlights
several developments which can assist diseases combined with supporting drivers
and restraints for the period of 2017 and 2023 (forecast period).
Get Request
Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3933
Vocal Biomarkers Market Outlook
The global vocal
biomarkers market is bound to touch a valuation of USD 2.5 billion by 2023. It
can exhibit a CAGR of 14.3% during the forecast period. It is driven the
prevalence of various neurological and psychological diseases such as
Huntington’s disease, Alzheimer’s disease, Parkinson’s disease, depression,
attention deficit and disruptive behavior disorders, traumatic brain injury,
and others. According to the WHO, close to 350 million suffered from depression
in 2016 and the Parkinson’s disease Foundation estimated the number of patients
affected by the disease to be reaching a number of 10 million in the same year.
Various
government organizations are partnering up with private clinics and firms to
develop machine learning algorithms for initial detection of diseases. This is
exemplified by the alliance of American Heart Association with Mayo Clinic and
Beyond Verbal to use voice patterns to detect coronary heart disease at its
initial stage. Development of smartphone applications to detect all disease
from voice or sounds can provide the global vocal biomarkers the much-needed
impetus in the coming years.
You can Also
Read Here!! https://www.medgadget.com/2019/06/vocal-biomarkers-market-2019-information-by-type-by-indications-by-end-user-global-size-share-analysis-regional-growth-demand-and-business-opportunities.html
Vocal Biomarkers Market Segmentation Analysis
The global vocal biomarkers market is segmented by type,
indication, and end-user.
The global market, by type is segmented into pitch, voice tremor,
vocal rise or fall time, phonation time, error rate, amplitude, frequency, and
others.
The market, by indication, is segmented into neurological
disorders, psychiatric disorders, cardiovascular disorders, respiratory
disorders, and others.
Based on end-user, the market is segmented into academic and
research, hospitals and clinics, and others.
Vocal Biomarkers Market Regional Analysis
The Middle East
& Africa (MEA), Americas, Europe, and Asia Pacific (APAC) are major regions
in the global vocal biomarkers market.
The Americas is
predicted to dominate the global market due to the U.S. grabbing maximum shares
owing to large healthcare expenditure and favorable reimbursement schemes. The
fast adoption rate of new technology can be pivotal in driving the vocal
biomarkers market. Alternatives to MRI/CT/EEG machines will find demand due to
the large elderly populace in the region.
Europe is the
second-biggest region for the market due to large awareness levels and
expendable income levels of patients. In addition, the need for non-invasive
techniques for detection of diseases is ensured to gain traction and pave way
for the global vocal biomarkers market.
The APAC region
is expected to have the largest potential for the market due to the large
patient pool in China and India. On the other hand, the MEA region will
contribute to the vocal biomarkers market due to the booming medical sector in
Saudi Arabia and UAE.
Vocal Biomarkers Market Competitive Outlook
Audio Profiling, Sonde
Health, IBM Corporation, Beyond Verbal, Cogito Corporation, and others are
reputed companies currently operating in the global vocal biomarkers market.
Industry
Update
Sonde Health has managed
to raise close to USD 16 million in series A funding to spur the development of
vocal biomarkers. The technology has amassed hundreds of vocal characteristics
from recordings to identify changes in pitch, rate of speech, and hoarseness to
assess health.
Aural
Analytics has published the results of a clinical trial involving the effects
of reldesemtiv, a skeletal muscle troponin activator, used in the treatment of
spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS). The
company analyzed vocal biomarkers for the duration of the trial to notice any
improvements in speech patterns.
Read more @ https://www.marketresearchfuture.com/reports/vocal-biomarkers-market-3933
About Market
Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by Components, Application, Logistics and market
players for global, regional, and country level market segments, enable our
clients to see more, know more, and do more, which help to answer all their
most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of
researchers are studying Covid19 and its impact on various industry verticals
and wherever required we will be considering covid19 footprints for a better
analysis of markets and industries. Cordially get in touch for more details.
